← All diseases
Cancer
Chronic lymphocytic leukemia
Would you like to receive a message when there is new research on Chronic Lymphocytic Leukemia? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, a sentence above each publication explains what was studied — and you'll receive a notification as soon as there is new research about Chronic lymphocytic leukemia. View what Premium costs.
Publications and studies (1769)
- Incidence and clinical impact of absolute lymphocyte count-only progression in chronic lymphocytic leukemia. (2026/07/16) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Mechanisms of Clonal Expansion: Mutations, Methylation, and ncRNA Networks From Monoclonal B-Cell Lymphocytosis to Chronic Lymphocytic Leukemia. (2026/07/15) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Safety and Management of Targeted Therapies for Relapsed/Refractory Chronic Lymphocytic Leukemia. (2026/07/15) ♡
- The Danish Lymphoid Cancer Research (DALY-CARE): Genetic Cohort Profile. (2026/07/15) ♡
- The CD19-4-1BBL antibody fusion protein unleashes the immune system against high-risk chronic lymphocytic leukemia. (2026/07/15) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Chronic lymphocytic leukemia management in India: balancing evidence, access, and affordability in clinical practice. (2026/07/15) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Response to comments on "Measurable residual disease after venetoclax treatment for relapsed or refractory chronic lymphocytic leukemia in Japan". (2026/07/14) ♡
- Renal Involvement in Indolent and Aggressive B-Cell Neoplasms: A Comparative Study of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma and Diffuse Large B-Cell Lymphoma. (2026/07/14) ♡
- Self-explaining artificial intelligence for the classification of B cell non-Hodgkin lymphoma: A diagnostic decision support study. (2026/07/13) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Preclinical and clinical efficacy of the HDAC6 inhibitor ricolinostat in combination with BCR pathway inhibitors in relapsed/refractory chronic lymphocytic leukemia. (2026/07/13) ♡
- Computer-guided dosing of multi-specific T-cell engagers. (2026/07/13) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Polypharmacy in Chronic Lymphocytic Leukemia in the Era of Targeted Agents: A Medication Stewardship Perspective. (2026/07/12) ♡
- When a paraneoplastic lesion meets its maker—bilateral periocular skin and orbital collision of chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) and necrobiotic xanthogranuloma (NBX) in the same biopsy. (2026/07/12) ♡
- Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. The pharmacokinetics and its covariates of rituximab in different clinical populations: a systematic review and narrative synthesis. (2026/07/10) ♡
- A novel Vδ1 engager targeting CD19 enhances human Vδ1 γδ T cell responses against CLL and CD19+ hematological malignancies. (2026/07/10) ♡
- Expanding the Horizon of CAR-T Cell Therapy: Present Obstacles and New Strategies for Future CARs in Solid Tumors. (2026/07/10) ♡
- Efficacy of high-frequency low-dose rituximab and acalabrutinib in chronic lymphocytic leukemia. (2026/07/08) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. STAT3 as a Candidate Shared Regulator of the CXCR4/CXCL12 and CXCR5/CXCL13 Homing Axes in Chronic Lymphocytic Leukemia. (2026/07/08) ♡
- Australasian chronic lymphocytic leukemia consensus statement: 2026 update. (2026/07/07) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Measurable residual disease is not a universally reliable surrogate for progression-free survival in clinical trials of new chronic lymphocytic leukemia therapies. (2026/07/07) ♡
- Embedding cardiovascular risk assessment into routine BTK inhibitor management in chronic lymphocytic leukemia. (2026/07/06) ♡
- Phase 3 studyiResearch in a large group of patients, the final step before a treatment can be approved. What comes out here carries significant weight. Orelabrutinib versus chemoimmunotherapy in treatment-naïve chronic lymphocytic leukemia/small lymphocytic lymphoma: a randomized, phase 3 trial. (2026/07/06) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The essentials—measurable residual disease in hematopoietic neoplasms: current testing landscape and future directions. (2026/07/06) ♡
- Stereoselective Covalent Targeting of BTK(C481S) and Kinases with β-Lactone Electrophiles. (2026/07/06) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Taginostat, a new quinolone-based HDAC6 inhibitor, promotes apoptosis of chronic lymphocytic leukemia cells in vitro and in vivo by activating STAT4. (2026/07/04) ♡
- Acute Kidney Injury Due to Granulomatous Interstitial Nephritis as the Initial Presentation of CLL/SLL Treated with Acalabrutinib. (2026/07/04) ♡
- Real-world treatment patterns and outcomes in chronic lymphocytic leukemia: a multicenter retrospective study in Greece. (2026/07/03) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Chronic Lymphocytic Leukemia (CLL)-Associated Proliferative Glomerulonephritis With Monoclonal Immunoglobulin Deposits (PGNMID) Diagnosed in the Absence of Detectable Paraprotein. (2026/07/03) ♡
- The prognostic implications of autoimmune hemolytic anemia in chronic lymphocytic leukemia across treatment eras. (2026/07/02) ♡
- Vitamin D Supplementation and Treatment-Free Survival in Early-Stage CLL: A Real-World Validation Study. (2026/07/02) ♡
- Real-world effectiveness and safety of acalabrutinib in chronic lymphocytic leukaemia: Multicentre experience. (2026/07/02) ♡
- Analysis of factors influencing SARS-CoV-2 infection and outcomes in patients with chronic lymphocytic leukemia during the burst of COVID-19 epidemic. (2026/07/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Hoarseness as a Manifestation of Chronic Lymphocytic Leukemia Involving the Larynx. (2026/07/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. New-Onset Vitiligo During Dupilumab Treatment: A Clinical Observation and Literature Review. (2026/07/01) ♡
- Quality by design-based development of ibrutinib polymer-lipid hybrid nanoparticles for enhanced lymphatic absorption and anticancer efficacy. (2026/07/01) ♡
- [Berberine induces apoptosis in chronic lymphocytic leukemia B cells by targeting Lyn and inhibiting the BCR pathway]. (2026/07/01) ♡
- Machine Learning for Prediction of High-Risk Infections in Patients With Cancer. (2026/07/01) ♡
- A comprehensive analysis of the incidence of chromosomal abnormalities in hematologic malignancies post-COVID-19 outbreak in King Chulalongkorn Memorial Hospital, Thailand. (2026/06/30) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Role of Autologous Haematopoietic Transplantation in Leukaemias: When to Consider It in 2026. (2026/06/29) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Complex TP53 Alterations with del(17p) and del(13q) in Chronic Lymphocytic Leukemia: Clinical Implications from a Case-Based Review. (2026/06/28) ♡
- Baseline Clinical and Laboratory Predictors of Treatment Requirement in Chronic Lymphocytic Leukemia: A Retrospective Cohort Study Using Hierarchical Modeling. (2026/06/26) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Mechanisms of resistance to BTK inhibitors in B cell malignancies and emerging targeted strategies. (2026/06/26) ♡
- Physical Fitness in Ambulatory Patients with Chronic Lymphoid Malignancies Receiving Monoclonal Antibody-Based Therapy: A Case-Control Study. (2026/06/24) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Venetoclax-associated bullous dermatitis: A BCL-2 inhibitor-linked autoimmune blistering disease. (2026/06/20) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Enhancing immunotherapy efficacy in multiple myeloma and chronic lymphocytic leukemia: from combinatorial therapeutic approaches to gut microbiota modulation. (2026/06/17) ♡
- Gastrointestinal toxicity in the treatment of hematological tumors. Influence on nutritional status. (2026/06/15) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Rare CNS manifestation of high-risk CLL with excellent response to triplet targeted therapy. (2026/06/12) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Fulminant Mantle Cell Lymphoma Presenting With Hepatic Infiltration and Spontaneous Tumor Lysis Syndrome. (2026/06/04) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Second Primary Malignancies in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Comprehensive Review. (2026/06/04) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Disappearance of the Defining Organized Ultrastructural Lesion in Chronic Lymphocytic Leukemia-Associated Monoclonal Immunotactoid Glomerulopathy After Ibrutinib Therapy. (2026/06/03) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.